The BoC Cannabis Index closed Tuesday with a marginal +0.34% gain that masks a sharp split inside the sector. US multi-state operators ripped higher, with seven names notching gains north of 4%, while every cannabis ETF in the index finished red — a divergence that points to ETF flows rotating out even as cash MSOs caught a bid.
Breadth was negative on a name count: 22 stocks fell against 17 advancers across the 39 constituents that printed today. The pull-down came from Canadian LPs, the four cannabis ETFs (MSOS, MJ, CNBS, YOLO) all losing between 2.4% and 3.7%, and a handful of small-cap blow-ups. The MSO cohort and a steady tobacco/pharma bid (MO +2.73%, JAZZ +1.37%) kept the equal-weighted index in the green.
| Ticker | Price | Change ($) | Change (%) |
|---|---|---|---|
| CRLBF | $1.19 | +$0.1900 | +19.00% |
| GTBIF | $8.29 | +$1.01 | +13.85% |
| JUSHF | $0.5729 | +$0.0634 | +12.43% |
| AAWH | $0.5897 | +$0.0597 | +11.26% |
| GLASF | $10.54 | +$0.8655 | +8.95% |
| TCNNF | $9.42 | +$0.7100 | +8.15% |
| VEXTF | $0.2120 | +$0.0114 | +5.68% |
| VRNOF | $1.12 | +$0.0500 | +4.67% |
| CURLF | $3.44 | +$0.1400 | +4.24% |
| EEX | $5.02 | +$0.1900 | +3.93% |
| MO | $67.80 | +$1.80 | +2.73% |
| MAPS | $0.3790 | +$0.0052 | +1.39% |
| JAZZ | $203.98 | +$2.76 | +1.37% |
| IIPR | $56.01 | +$0.2500 | +0.45% |
| IXHL | $4.08 | +$0.0100 | +0.25% |
| STZ | $155.39 | +$0.3100 | +0.20% |
| ABBV | $197.69 | +$0.3100 | +0.16% |
| REFI | $12.16 | -$0.0800 | -0.65% |
| CBWTF | $0.1036 | -$0.0014 | -1.31% |
| HITI | $2.51 | -$0.0400 | -1.57% |
| CRON | $2.65 | -$0.0500 | -1.85% |
| AFCG | $2.93 | -$0.0600 | -2.01% |
| YOLO | $3.21 | -$0.0774 | -2.35% |
| ACB | $3.42 | -$0.0900 | -2.56% |
| CRBP | $9.82 | -$0.2600 | -2.58% |
| SNDL | $1.47 | -$0.0400 | -2.65% |
| OGI | $1.40 | -$0.0400 | -2.78% |
| GRWG | $1.34 | -$0.0400 | -2.90% |
| TPB | $77.42 | -$2.46 | -3.08% |
| VFF | $2.80 | -$0.0900 | -3.11% |
| MJ | $27.82 | -$0.9900 | -3.44% |
| MSOS | $4.97 | -$0.1800 | -3.50% |
| SMG | $65.38 | -$2.40 | -3.54% |
| CNBS | $29.17 | -$1.11 | -3.67% |
| CGC | $1.15 | -$0.0500 | -4.17% |
| TLRY | $6.56 | -$0.3300 | -4.79% |
| IMCC | $0.2569 | -$0.0197 | -7.12% |
| IPW | $0.9059 | -$0.0791 | -8.03% |
| AYRWF | $0.0115 | -$0.0025 | -17.86% |
Cresco Labs led the tape with a 19.00% gain to $1.19, with CRLBF joined by GTBIF (+13.85%), JUSHF (+12.43%) and AAWH (+11.26%) — a coordinated bid across the largest US MSOs that had no immediate news catalyst beyond renewed federal-rescheduling chatter and short covering at depressed levels. On the other side, Ayr Wellness — sub-penny AYRWF trades at $0.0115 — collapsed 17.86% on no immediate news catalyst, with IPW (-8.03%) and IMCC (-7.12%) the next-worst small caps. Among the US multi-state operators, GLASF (+8.95%) and TCNNF (+8.15%) reinforced the cohort move; the ETF print is the curiosity, with MSOS down -3.50% even as its top US-listed underlyings rallied — a mechanical lag that could reverse in tomorrow’s session.
Tobacco and pharma names tied to the broader cannabinoid story were quietly constructive: Altria added 2.73%, Constellation Brands held +0.20%, and Jazz Pharmaceuticals picked up 1.37%. The cannabis REIT/lender complex was mixed, with IIPR +0.45% and AFCG -2.01%.
Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.
